Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Högberg

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Drug Design and Discovery|January 1, 1993
The development of dopamine D2-receptor selective antagonistsT Högberg
Annals of Medicine|February 1, 1995
Primary surgery in ovarian cancer: current opinionsT Högberg
Lakartidningen|June 26, 1998
[A new therapeutic program in advanced ovarian cancer. Good results with decentralized cytostatic therapy]E Henic, T Högberg
Acta Pharmaceutica Nordica|January 1, 1992
A quantitative structure-activity relationship for some dopamine D2 antagonists of benzamide typeU Norinder, T Högberg
Acta Chemica Scandinavica (Copenhagen, Denmark : 1989)|April 1, 1992
PLS-based quantitative structure-activity relationship for substituted benzamides of clebopride type. Application of experimental design in drug designU Norinder, T Högberg
Gynecologic Oncology|August 1, 1992
Long-term follow-up of ovarian cancer with monthly determinations of serum CA 125T Högberg, B Kågedal
Acta Pharmaceutica Nordica|January 1, 1992
Molecular and crystal structure of the hydrochloride monohydrate of (R)-N-[[1-(4-fluorobenzyl)-2-pyrrolidinyl]methyl]-5-bromo-2,3- dimethoxybenzamide, NCQ 115, a novel dopamine D2 receptor antagonistI Csöregh, T Högberg
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1990
Serum half-life of the tumor marker CA 125 during induction chemotherapy as a prognostic indicator for survival in ovarian carcinomaT Högberg, B Kågedal
Gynecologic Oncology|January 1, 1993
Treatment results and prognostic factors in a population-based study of epithelial ovarian cancerT Högberg, J Carstensen, E Simonsen
Acta Oncologica (Stockholm, Sweden)|July 10, 2001
A systematic overview of chemotherapy effects in ovarian cancerT Högberg, B Glimelius, P Nygren, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Drug Design and Discovery|January 1, 1993
The development of dopamine D2-receptor selective antagonistsT Högberg
Annals of Medicine|February 1, 1995
Primary surgery in ovarian cancer: current opinionsT Högberg
Lakartidningen|June 26, 1998
[A new therapeutic program in advanced ovarian cancer. Good results with decentralized cytostatic therapy]E Henic, T Högberg
Acta Pharmaceutica Nordica|January 1, 1992
A quantitative structure-activity relationship for some dopamine D2 antagonists of benzamide typeU Norinder, T Högberg
Acta Chemica Scandinavica (Copenhagen, Denmark : 1989)|April 1, 1992
PLS-based quantitative structure-activity relationship for substituted benzamides of clebopride type. Application of experimental design in drug designU Norinder, T Högberg
Gynecologic Oncology|August 1, 1992
Long-term follow-up of ovarian cancer with monthly determinations of serum CA 125T Högberg, B Kågedal
Acta Pharmaceutica Nordica|January 1, 1992
Molecular and crystal structure of the hydrochloride monohydrate of (R)-N-[[1-(4-fluorobenzyl)-2-pyrrolidinyl]methyl]-5-bromo-2,3- dimethoxybenzamide, NCQ 115, a novel dopamine D2 receptor antagonistI Csöregh, T Högberg
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1990
Serum half-life of the tumor marker CA 125 during induction chemotherapy as a prognostic indicator for survival in ovarian carcinomaT Högberg, B Kågedal
Gynecologic Oncology|January 1, 1993
Treatment results and prognostic factors in a population-based study of epithelial ovarian cancerT Högberg, J Carstensen, E Simonsen
Acta Oncologica (Stockholm, Sweden)|July 10, 2001
A systematic overview of chemotherapy effects in ovarian cancerT Högberg, B Glimelius, P Nygren, et al.
Pageof 7